Investing in the Future of Scalable, Precision Healthcare.
A unique fusion of AI-based technologies and clinically validated interventions, tackling the £300 billion mental health crisis.
Invest in Better
The Market Problem
Demand for mental health care globally far exceeds capacity, leading to large waiting lists or no treatment at all
NHS referrals reached
NHS referrals recovered
UK mental health cost
Bridging the Gap Between AI and Clinical Empathy
We have built a sophisticated ecosystem of AI-based digital technologies. Our tools are tailored for different languages, cultures, and personal needs, developed over six years with an international team of experts.
The "Engine":
- StratCare: AI assessment proven effective in RCTs; recommendations for relevant treatment.
- AI Oracle: Intelligent tracking and recovery prediction. Awarded "Best Innovation" in 2024 for a 30% increase in patient recovery.
- Ai-Leap & UpLift: Our NHS-approved platforms for creating and delivering engaging, evidence-based content.
Milestones:
- Proven Effectiveness: Successful results across 5 large-scale NHS RCTs.
- Upcoming Growth: 6 NHS trusts confirmed for new RCTs in 2025.
- IP Protection: Multiple US patents granted.
- Funding Validation: Secured funding from Innovate UK for dual RCTs.
Proven Track Record
Tuvi Orbach
MindLife Founder & CEO
Serial entrepreneur with a track record of scaling digital health solutions globally.
Tuvi was the founder of Sapiens International (recently acquired for $2.5 billion). He sold his shares after establishing international operations, but before Sapiens became a public company, to pursue a mission he considered more important: integrating advanced science and psychology with cutting-edge digital technology to develop scalable solutions to improve people’s lives.
His team, in collaboration with the Institute of Psychiatry, developed Beating the Blues, the first computerised CBT treatment for depression recommended by NICE, helping pioneer evidence-based digital mental healthcare.
MindLife continues this mission, harnessing the latest technologies to develop advanced, scalable solutions that improve and uplift people’s lives.
Scalable Growth. Sustainable Impact.
Strategic Roadmap: Starting with NHS licensing and resellers, followed by a US rollout targeting insurers, Medicare, and Medicaid.
Investment Goal: Seeking at least £1 million to expand solutions within the NHS and internationally.
Tax Efficiency (UK Investors):
- EIS & Knowledge Intensive Benefits: MindLife qualifies as a Knowledge Intensive Company (KIC), allowing for enhanced tax relief.
- Immediate Returns: Receive 30% of your investment back via income tax relief.
- Future Gains: Shares held for 3+ years are exempt from Capital Gains Tax.